Apreciapharmaceuticals
Apreciapharmaceuticals, operating as Aprecia Pharmaceuticals, is a pioneering specialty CDMO focused on 3D‑printed drug manufacturing. Founded in 2003 and based in Langhorne, PA, the company offers end‑to‑end development, clinical‑trial supply, and commercial‑scale production using FDA‑registered cGMP facilities. It is the world’s first to secure regulatory approval for a 3D‑printed medication (SPRITAM®) and continues to innovate in precision formulation, rapid prototyping, and flexible manufacturing to accelerate patient‑centered drug development.
Apreciapharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, 3D Printing, CDMO, and FDA.
Apreciapharmaceuticals’ developer surface includes engineering blog and 11 more developer resources.
Kin Score
Terms of Service 1
What its API terms permit and prohibit, quoted from its own page.
Apreciapharmaceuticals
7 quoted statements, read from Apreciapharmaceuticals's own page on 2026-11-09.
TERMSPrivacy & Data 1
Its role, the data it processes, retention and transfers, quoted from its own privacy page.
Apreciapharmaceuticals
21 quoted statements, read from Apreciapharmaceuticals's own page on 2026-11-09.
PRIVACYEligibility 1
Who may sign up and where, quoted from its own terms.
Apreciapharmaceuticals
1 quoted statement, read from Apreciapharmaceuticals's own page on 2026-11-09.
ELIGIBILITYData License 1
How its data and outputs may be reused, quoted from its own terms.
Apreciapharmaceuticals
1 quoted statement, read from Apreciapharmaceuticals's own page on 2026-11-09.
LICENSESecurity Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 4
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Other 4
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.